WINKF yields 11695.91% · PFE yields 6.13%● Live data
📍 WINKF pulled ahead of the other in Year 1
Combined, WINKF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WINKF + PFE for your $10,000?
Windfall Geotek Inc. develops platforms for the mining sector. The company offers computer aided resource detection system, a platform to analyze digital data sets of georeferenced historical exploration data, including geological, geochemical, geophysical, structural, and digital elevation data; and data mining services. It also acquires, explores for, and develops mineral resource properties in Québec. The company has an option agreement to hold 90% undivided interest in the Chapais project that comprises 36 claims located in Quebec; and 95% undivided interest in the Corallen Lake property that comprises 348 claims. It also owns 5,240 claims in the province of Ontario; 1,078 claims in the province of Quebec; and 11 claims in the province of New Brunswick. The company was formerly known as Albert Mining Inc. and changed its name to Windfall Geotek Inc. in October 2019. Windfall Geotek Inc. was incorporated in 1996 and is headquartered in Brossard, Canada.
Full WINKF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.